Helen Blake
Interventional Pain Medicine · Chesterfield, MONPI 1245438597
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Abbott at 39.0% of the total. Reporting peaked in 2021 at $13,691 and has fallen 78.7% since, to $2,922 in 2025. Among interventional pain medicine clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 239 payments — averaging $202.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$19K
- Axogen$11K
- Stratus Medical, LLC$10K
- Saluda Medical Americas, Inc.$4K
- Medtronic$1K
- Nevro Corp.$680
- plus $3K from 23 others
What the payments were for
- Consulting fees$24,27550%
- Speaking & faculty fees$9,98521%
- Travel & lodging$3,4167%
- Food & beverage$10,48522%
- Education$1210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 91 | $18,837 |
| Axogen | 13 | $10,837 |
| Stratus Medical, LLC | 25 | $10,143 |
| Saluda Medical Americas, Inc. | 20 | $4,147 |
| Medtronic(2 entities) | 21 | $1,110 |
| Nevro Corp. | 6 | $680 |
| SPR Therapeutics, Inc | 12 | $643 |
| Stimwave Technologies Incorporated | 5 | $402 |
| Foundation Fusion Solutions, LLC | 2 | $267 |
| MML US, Inc. | 2 | $186 |
| Si-bone, Inc. | 2 | $180 |
| Vertos Medical, Inc. | 1 | $153 |
| Electronic Waveform Lab, Inc. | 6 | $152 |
| Scilex Pharmaceuticals Inc. | 12 | $149 |
| Boston Scientific | 1 | $59 |
| Amgen(2 entities) | 3 | $52 |
| Novartis | 2 | $38 |
| Pacira Therapeutics, Inc. | 2 | $33 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| AbbVie(2 entities) | 2 | $28 |
| Bioventus LLC | 1 | $24 |
| Stryker | 1 | $22 |
| Pacira Cryotech Incorporated | 1 | $22 |
| Tersera Therapeutics LLC | 1 | $22 |
| Pfizer | 1 | $15 |
| Trevena, Inc. | 1 | $12 |
| AstraZeneca | 1 | $12 |
| Shionogi Inc | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nimbus$9,720
- IonicRF Generator$9,500
- AVANCE NERVE GRAFT$5,138
- PROCLAIM$3,246
- Evoke SCS$2,186
- AxoGuard Nerve Connector$1,914
- AxoGuard Nerve Protector$1,914
- Proclaim IPG$1,602
- Evoke$1,594
- Prodigy Family of SCS IPGs$575
- Proclaim XR IPG$419
- INTELLIS ADAPTIVESTIM$315
- ETERNA$292
- Senza$265
- Proclaim Family of SCS IPGs$251
- SPRINT PNS System$229
- Neuromodulation-Research Only$213
- Proclaim DRG IPG$200
- mild Device Kit$153
- SYNCHROMED$150
How this compares
$48,283 in reported general payments places this provider in the 90th percentile of 27 interventional pain medicine providers in Missouri.
See all interventional pain medicine providers in Missouri →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $403 |
| Gabapentin | 12 | $198 |
| Duloxetine Hcl | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Chesterfield
- Kaylea BoutwellChesterfield$5K
- Armin RahimiChesterfield$20
- Rebecca SandersJoplin$209K
- Ramis GheithBridgeton$73K
- Andrew FrazierKansas City$32K
- Christian OliverBridgeton$18K
- David TonkinSpringfield$14K
- Dwayne JonesKansas City$11K
- Bradford NobleColumbia$8K
- Calvin CajigalDes Peres$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.